The present study examined whether atorvastatin, when used for pharmacological
postconditioning, attenuated myocardial ischemia-reperfusion (I/R) injury in a manner …

We have developed a new “drug” and approach that appear to be effective in reducing
arterial age. This “drug” represents a low, subtherapeutic dose of statin and sartan and …

Healing of burn wounds is often associated with scar formation due to excessive
inflammation and delayed wound closure. To date, no effective treatment is available to …

This study aims to determine the effect of Lipoxin (LX) A 4 on myocardial ischemia
reperfusion injury (MIRI) in rats and the related molecular mechanisms. Male SD rats were …

The aim of this study was to investigate a fixed dose combination (FDC) of telmisartan (TEL)
and pravastatin sodium (PRA) in enteric-coated bilayer tablets, which was designed for once …

Mean platelet volume (MPV) is a well-established marker of platelet activation, and recent
studies have shown that platelet activation is central to the processes in the pathophysiology …

Background Atorvastatin and remote ischemic preconditioning (RIPC) have beneficial
cardiovascular protective effects. The aim of the study was to investigate possible effect of …

The aim of the present study was to investigate the effects of atorvastatin against heart
ischemia/reperfusion (I/R) injury and its potential underlying mechanism. Rats were …

Abstract Background and Aim: Previously, we have shown that slightly to moderately aged
arteries in middle-aged males can be rejuvenated functionally by sub-therapeutic, low-dose …

Background Atorvastatin could be beneficial in the treatment of burn patients to prevent burn
wound progression from partial to full thickness. Our primary aim is to evaluate the safety of …